Pharmacology · Anti-Mycobacterial Drugs (Anti-TB, Anti-Leprosy)

According to the WHO multidrug therapy schedule followed in India, which correctly describes the adult multibacillary leprosy regimen?

  • A Rifampicin 600 mg monthly supervised, clofazimine 300 mg monthly, dapsone 250 mg twice weekly, for 12 months
  • B Rifampicin 450 mg monthly supervised, dapsone 100 mg daily, for 6 months
  • C Rifampicin 600 mg daily, dapsone 100 mg daily, clofazimine 100 mg daily, for 24 months
  • D Rifampicin 600 mg monthly supervised, clofazimine 300 mg monthly plus 50 mg daily, dapsone 100 mg daily, for 12 months
Correct answer: D. Rifampicin 600 mg monthly supervised, clofazimine 300 mg monthly plus 50 mg daily, dapsone 100 mg daily, for 12 months

Explanation

Multibacillary MDT comprises rifampicin 600 mg once monthly supervised, clofazimine 300 mg once monthly supervised plus 50 mg self-administered daily, and dapsone 100 mg self-administered daily, for 12 months. Option B describes the paucibacillary regimen of 6 months without clofazimine. Daily rifampicin is never used in MDT because of toxicity and cost, and dapsone is given daily, not intermittently.

Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Anti-Mycobacterial Drugs (Anti-TB, Anti-Leprosy) MCQs

See all Anti-Mycobacterial Drugs (Anti-TB, Anti-Leprosy) MCQs →